摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2,3,4-tetrahydro-5,7-dimethyl-6H-pyrrolo<3,4-d>pyridazine-1,4-dione | 96441-74-6

中文名称
——
中文别名
——
英文名称
1,2,3,4-tetrahydro-5,7-dimethyl-6H-pyrrolo<3,4-d>pyridazine-1,4-dione
英文别名
5,7-dimethyl-2,3-dihydro-6H-pyrrolo[3,4-d]pyridazine-1,4-dione;5,7-Dimethyl-2,3-dihydro-6H-pyrrolo[3,4-d]pyridazin-1,4-dion;1,2,3,4-Tetrahydro-5,7-dimethylpyrrolo<3,4-d>pyridazin-1,4-dion;5,7-dimethyl-3,6-dihydro-2H-pyrrolo[3,4-d]pyridazine-1,4-dione
1,2,3,4-tetrahydro-5,7-dimethyl-6H-pyrrolo<3,4-d>pyridazine-1,4-dione化学式
CAS
96441-74-6
化学式
C8H9N3O2
mdl
——
分子量
179.178
InChiKey
HXSKFERRZBDPLK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    74
  • 氢给体数:
    3
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    diethyl 2,5-dimethyl-1H-pyrrole-3,4-dicarboxylate一水合肼 作用下, 反应 120.0h, 以85%的产率得到1,2,3,4-tetrahydro-5,7-dimethyl-6H-pyrrolo<3,4-d>pyridazine-1,4-dione
    参考文献:
    名称:
    吡咯研究:31.潜在互变异构的1,2-二氢-6-吡咯并[3,4- ]哒嗪-1-酮和1,2,3,4-四氢-6-吡咯并[3,4- ]的结构哒嗪-1,4-二酮
    摘要:
    1,2-二氢-6H-吡咯并[3,4- ]哒嗪-1-酮主要以这种形式(10 4-47:1)与1-羟基哒嗪形式平衡存在,而1,2,3,4-与单羟基-氧代互变异构形式平衡的四氢-6-吡咯并-[3,4- ]哒嗪-1,4-二酮是优选的。100:1。这是不可能的,以确定平衡的1-羟基- 6之间的位置-吡咯并[3,4 ]哒嗪-4-酮和1,4-二羟基-6- -吡咯并[3,4- ]哒嗪结构。
    DOI:
    10.1016/0040-4020(84)85076-0
点击查看最新优质反应信息

文献信息

  • Zur Kenntnis heterozyklischer Ringsysteme III
    作者:Reinhard Seka、Heinrich Preissecker
    DOI:10.1007/bf01522111
    日期:1931.2
  • Pyrrole studies: 31. The structures of potentially tautomeric 1,2-dihydro-6-pyrrolo [3,4-]pyridazine-1-ones and 1,2,3,4-tetrahydro-6-pyrrolo [3,4-]pyridazine-1,4-diones
    作者:Sermin Inel、R. Alan Jones、Cemil Ogretir
    DOI:10.1016/0040-4020(84)85076-0
    日期:1984.1
    2-Dihydro-6H-pyrrolo[3,4-]pyridazine-1-ones exist predominantly as such (104-47: 1) in equilibrium with the 1-hydroxypyridazine form, whereas 1,2,3,4-tetrahydro-6-pyrrolo-[3,4-]pyridazine-1,4-diones in equilibrium with the monohydroxy-oxo tautomeric forms are preferred by a factor of only . 100 : 1. It was not possible to determine the position of equilibrium between the 1-hydroxy-6-pyrrolo[3,4-]pyridazine-4-one
    1,2-二氢-6H-吡咯并[3,4- ]哒嗪-1-酮主要以这种形式(10 4-47:1)与1-羟基哒嗪形式平衡存在,而1,2,3,4-与单羟基-氧代互变异构形式平衡的四氢-6-吡咯并-[3,4- ]哒嗪-1,4-二酮是优选的。100:1。这是不可能的,以确定平衡的1-羟基- 6之间的位置-吡咯并[3,4 ]哒嗪-4-酮和1,4-二羟基-6- -吡咯并[3,4- ]哒嗪结构。
查看更多

同类化合物

5,6,7-三甲基-2,6-二氢-1H-吡咯并[3,4-d]吡嗪-1-酮 1-氯-5,6,7-三甲基-6H-吡咯并[3,4-d]吡嗪盐酸盐 4-(5,7-dimethyl-1-oxo-2-phenyl-1H-pyrrolo[3,4-d]pyridazin-6(2H)-yl)butanoic acid 2,6-dihydro-2-methyl-4-(2-methylpropyl)-6-phenylmethyl-1H-pyrrolo[3,4-d]pyridazin-1-one 1-chloro-4-ethoxy-5,6,7-trimethyl-6H-pyrrolo<3,4-d>pyridazine 1,4-dichloro-5,6,7-trimethyl-6H-pyrrolo<3,4-d>pyridazine 1,4-dichloro-6-isopropyl-6H-pyrrolo[3,4-d]pyridazine ethyl 4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-7-methyl-6H-pyrrolo[3,4-d]pyridazine-5-carboxylate 1,2-dihydro-5,7-dimethyl-6H-pyrrolo<3,4-d>pyridazine-1-one 1,2-dihydro-2,5,7-trimethyl-6H-pyrrolo<3,4-d>pyridazine-1-one 1-ethoxy-5,6,7-trimethyl-6H-pyrrolo<3,4-d>pyridazine 2,8-dichloro-6-methylpyrrolo<1,2-b:3,4-d'>dipyridazin-5(6H)-one 5,6,7-trimethyl-6H-pyrrolo<3,4-d>pyridazine 1,4,5,7-tetramethyl-6H-pyrrolo[3,4-d]pyridazine 1,4,5,7-tetramethyl-pyrrolo[3,4-d]pyridazin-6-ylamine 5,7-di-2-thienyl-2,3-dihydro-1H-pyrrolo[3,4-d]pyridazine-1,4(6H)-dione 2,3-dihydro-6H-pyrrolo[3,4-d]pyridazine-1,4-dione 5,7-dimethyl-6H-pyrrolo<3,4-d>pyridazine 1,2,3,4-tetrahydro-5,7-dimethyl-6H-pyrrolo<3,4-d>pyridazine-1,4-dione 5,10-Dihydro-2,3-dimethoxypyridazino<4',5':3,4>pyrrolo<2,1-a>isochinolin-9(6H)-on 6-Butyl-4-hydroxy-2,5,7-trimethyl-2,6-dihydro-pyrrolo[3,4-d]pyridazin-1-one 4-{5,7-Dimethyl-1-oxo-2-phenyl-1H,2H,6H-pyrrolo[3,4-D]pyridazin-6-YL}-N-(propan-2-YL)butanamide 2-{6-[(4-Fluorophenyl)methyl]-5,7-dimethyl-1-oxo-1H,2H,6H-pyrrolo[3,4-D]pyridazin-2-YL}-N-(4-methylcyclohexyl)acetamide N-[3-(Azepan-1-YL)propyl]-2-{5,7-dimethyl-6-[(4-methylphenyl)methyl]-1-oxo-1H,2H,6H-pyrrolo[3,4-D]pyridazin-2-YL}acetamide N-[2-(Cyclohex-1-EN-1-YL)ethyl]-4-{5,7-dimethyl-1-oxo-2-phenyl-1H,2H,6H-pyrrolo[3,4-D]pyridazin-6-YL}butanamide (6E)-2-methoxy-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 8-chloro-6-methyl-2-(4-methylpiperidin-1-yl)pyrrolo[1,2-b:3,4-d']dipyridazin-5(6H)-one 6-(5-Ethoxypyrazin-2-yl)-1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazine 4,5-dimethoxy-N-phenylmethoxy-10,14,15-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(17),2,4,6,11,13,15-heptaen-13-amine;hydrochloride 6-[4-(4-Ethylpiperazin-1-YL)-4-oxobutyl]-5,7-dimethyl-2-phenyl-1H,2H,6H-pyrrolo[3,4-D]pyridazin-1-one N-benzyl-4-(5,7-dimethyl-4-oxo-3-phenylpyrrolo[3,4-d]pyridazin-6-yl)-N-methylbutanamide 6-[(1S)-1-(4-methoxyphenyl)ethyl]-1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazine 6-[(4-fluorophenyl)methyl]-5,7-dimethyl-2H-pyrrolo[3,4-d]pyridazin-1-one 4,5-dimethoxy-N-phenylmethoxy-10,14,15-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(17),2,4,6,11,13,15-heptaen-13-amine 4-(phenylhydrazinylidene)-2-[(Z)-(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)iminomethyl]cyclohexa-2,5-dien-1-one 4-(phenylhydrazinylidene)-2-[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)iminomethyl]cyclohexa-2,5-dien-1-one 2,4-dibromo-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 4-chloro-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 2-methoxy-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 4-bromo-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 2,4-dichloro-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 2-prop-2-enyl-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 6-[1-(4-ethylpiperazin-1-yl)-1-oxopropan-2-yl]-5,7-dimethyl-2-phenyl-1H,2H,6H-pyrrolo[3,4-d]pyridazin-1-one 2-{5,7-Dimethyl-1-oxo-2-phenyl-1H,2H,6H-pyrrolo[3,4-D]pyridazin-6-YL}-N-[(2-ethoxyphenyl)methyl]acetamide 2-(5,7-dimethyl-4-oxo-3-phenylpyrrolo[3,4-d]pyridazin-6-yl)-N-methylpropanamide 2-(6-benzyl-5,7-dimethyl-4-oxopyrrolo[3,4-d]pyridazin-3-yl)-N-methylacetamide 4-{5,7-Dimethyl-1-oxo-2-phenyl-1H,2H,6H-pyrrolo[3,4-D]pyridazin-6-YL}-N-(2-phenylethyl)butanamide 2-(5,7-dimethyl-4-oxo-3-phenylpyrrolo[3,4-d]pyridazin-6-yl)-N-propan-2-ylacetamide N,N-Diethyl-2-{6-[(2-fluorophenyl)methyl]-5,7-dimethyl-1-oxo-1H,2H,6H-pyrrolo[3,4-D]pyridazin-2-YL}acetamide